+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Tips on How to Collect and Administer the Mesenchymal Stem Cell Secretome for Central Nervous System Applications



Tips on How to Collect and Administer the Mesenchymal Stem Cell Secretome for Central Nervous System Applications



Methods in Molecular Biology 1416: 457-465



Human mesenchymal stem cells (hMSCs) have been proposed as possible therapeutic agents for central nervous system (CNS) disorders. Recently, it has been suggested that their effects are mostly mediated through their secretome, which contains a number of neuroregulatory molecules capable of increasing cell proliferation, differentiation, and survival in different physiological conditions. Here, we present an overview of the hMSC secretome as a possible candidate in the creation of new cell-free therapies, demonstrating the process of its collection and route of administration, focusing our attention on their effects in CNS regenerative medicine.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059136632

Download citation: RISBibTeXText

PMID: 27236689

DOI: 10.1007/978-1-4939-3584-0_27


Related references

Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. Current Stem Cell Research and Therapy 6(3): 221-228, 2011

Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?. Cellular and Molecular Life Sciences 70(20): 3871-3882, 2013

Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis. Stem Cells Translational Medicine 1(7): 536-547, 2012

The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem Cell Research and Therapy 3(3): 18, 2012

Biological restoration of central nervous system architecture and function: part 3-stem cell- and cell-based applications and realities in the biological management of central nervous system disorders: traumatic, vascular, and epilepsy disorders. Neurosurgery 65(5): 831, 2009

Tackling the physiological barriers for successful mesenchymal stem cell transplantation into the central nervous system. Stem Cell Research and Therapy 4(4): 101, 2013

Microenvironment regulation of pluripotent stem cell-derived neural progenitor aggregates by human mesenchymal stem cell secretome. Tissue Engineering. Part a 20(19-20): 2666-2679, 2014

Secretome of Olfactory Mucosa Mesenchymal Stem Cell, a Multiple Potential Stem Cell. Stem Cells International 2016: 1243659, 2016

Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis. Stem Cell Research and Therapy 7: 43, 2016

Murine mesenchymal stem cells transplanted to the central nervous system of neonatal versus adult mice exhibit distinct engraftment kinetics and express receptors that guide neuronal cell migration. Stem Cells and Development 15(3): 437-447, 2006

Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation--an International Primary Central Nervous System Lymphoma Study Group project. Haematologica 98(5): 808-813, 2013

A New Paradigm in Cardiac Regeneration: The Mesenchymal Stem Cell Secretome. Stem Cells International 2015: 765846, 2015

Mesenchymal stem cell secretome and regenerative therapy after cancer. Biochimie 95(12): 2235-2245, 2013

Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie 95(12): 2196-2211, 2013